Mail Order Mifepristone Study

Completed · Phase 4

Conditions studied: Abortion Early, Pregnancy Related

In brief

This study aims to evaluate the feasibility, acceptability, and effectiveness of dispensing mifepristone via a mail-order pharmacy. The investigators will recruit patients at up to 10 primary care and internal medicines sites not currently providing abortion services around the country, as well as abortion clinic sites. Patients will go through routine in clinic visits to determine eligibility and then will receive the medications in the mail at their preferred address. The investigators will survey patients 3 and 14 days after the initial clinic visit and interview providers at the end of the study.

Key facts

Study ID
NCT03913104
Run by
Daniel Grossman, MD
People needed
536
Starts
2020-01-05
Expected to finish
2023-07-30
Last updated by the study team
2024-08-14

Who can join

Age: 15 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.